<DOC>
	<DOCNO>NCT02045875</DOCNO>
	<brief_summary>40 subject moderate-to-severe asthma randomly select study 20 , monitor medication use ( Dulera 100/5 , Dulera 200/5 Proventil HFA ) 3 month . These intervention subject receive medication use feedback visit , control group receive standard asthma care . Those interventional subject Dulera adherence &lt; 60 % receive feedback base asthma adherence disease management model protocol , Asthma Adherence Pathway . Intervention clinician train Motivational Interviewing reduce subject ambivalence medication use . The primary hypothesis subject receive medication monitor Motivational Interviewing adherence strategy well asthma control , measure Asthma Control Questionnaire , control group .</brief_summary>
	<brief_title>Improving Asthma Control Real World : A Systematic Approach Improving Dulera Adherence</brief_title>
	<detailed_description>Primary Clinical Hypothesis : Poorly control subject moderate-to-severe asthma ( measure Asthma Control Questionnaire ( ACQ ) ≥ 1 ) despite treatment Dulera , treat asthma adherence disease management protocol , Asthma Adherence Pathway™ , achieve great asthma control similar control subject treat current standard care . Primary end point : There four measure Asthma Control Questionnaire ( ACQ ) time 3 month . The primary endpoint third month measure ACQ . Secondary Clinical Hypothesis : The asthma adherence disease management program , Asthma Adherence Pathway™ , increase observe adherence Dulera relative benchmark 60 % adherence ( i.e. , expect prescribed actuation ) . Secondary end point : ) Average adherence Dulera three month study period Tertiary Clinical Hypothesis : Responses Adult Asthma Adherence Questionnaire ( AAAQ ) relate Dulera Adherence Tertiary Study Endpoints : There 2 measure AAAQ ( first last visit ) tertiary endpoint last visit</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Mometasone Furoate , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>1 . Physician diagnosis asthma moderate severity 2 . Subjects ≥ 18 year age 3 . Currently receive inhale corticosteroid medication prescribe Dulera 100/5 part standard care base upon asthma severity dose guideline 4 . Asthma Control Questionnaire ( ACQ ) result &gt; 1.0 entry 5 . Demonstration correct inhalation technique use meterdosed inhaler ( MDIs ) 6 . History reversible airway obstruction document treat physician Exclusion Criteria : intermittent asthma ; emphysema , chronic obstructive pulmonary disease ; chronic bronchitis ; cystic fibrosis ; medication may drug interaction Dulera Exclusion Criteria 1 . Intermittent asthma ( asthma exacerbation symptom &lt; 3 days/week ) 2 . Diagnosis emphysema prior year 3 . Diagnosis time : chronic obstructive pulmonary disease ( COPD ) , chronic bronchitis , cystic fibrosis , bronchiectasis , Churg Strauss , Wegener 's , sarcoidosis , pulmonary hypertension lung cancer 4 . On medication document drug interaction Dulera</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Adherence monitoring</keyword>
	<keyword>Motivational Interviewing Adherence strategy</keyword>
</DOC>